NEW YORK (GenomeWeb) – Danaher has completed its roughly $13.8 billion acquisition of Pall, a provider of filtration, separation, and purification products for life sciences and other applications.
Under terms of the merger, each outstanding share of Pall common stock was cancelled and converted into the right to receive $127.20 per share in cash.
The firms inked the deal in May. The $13.8 billion price tag includes assumed debt and is net of acquired cash.
At the time, Danaher said that following completion of the merger with Pall, it would split into two publicly traded companies. Danaher's existing Life Sciences & Diagnostics and Dental segments, water quality and product identification platforms, and Pall will comprise one firm, which will retain the Danaher name. The other firm will comprise Danaher's Test & Measurement instruments platform, as well as its specialty industrial businesses.